Sumitomo Pharma America, Inc
Senior Cell Therapy Process and Analytical Development Specialist at Sumitomo Pharma America, Inc.
Headquarters
Marlborough, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2023
N/A
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
Jul 30, 2025
Knight Therapeutics and Sumitomo Pharma enter into
Jun 5, 2025
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
Apr 22, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sumitomo Pharma America, Inc.
33% above the average for this role
Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it's Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®
Jun 30, 2025
Analytical Development Scientist - Cell Therapy
Capricor Therapeutics
Cell Foundry Lead
Vertex
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Senior/Principal Scientist, Analytical Cell Line Engineering and Bioassay Development
Takeda Pharmaceutical Company Limited
Pharma Cell Biologist
Cogent Scientific
Senior Research Associate, Cell Science
Systimmune